Latest update from the HPRA

The most recent update from the HPRA (Health Products Regulatory Authority) 6 March 2023 says: “Up to 28 February 2023, the HPRA has received a total of 20,917 reports describing suspected side effects in association with COVID-19 vaccines, of which 2,852 were received in 2022 and 158 were received in 2023.”

13,868 of the reports were related to mRNA vaccines (Pfizer’s Comirnaty® and Moderna’s Spikevax®) which is just over 66% of the total.

There was 6,707 reports made about Adenoviral vector vaccines (AstraZeneca’s Vaxzevria® and Johnson & Johnson’s Jcovden®) which is 32% of the total.

Some reports involved vaccination with more than one brand of vaccine, therefore the sum of the number of reports per vaccine type is greater than the total number of reports received.

Last December the European Medicines Agency’s (EMA) stopped giving monthly updates on reported Covid vaccine injuries.

The HPRA update states it “receives reports based on a suspicion that a side effect may be associated with vaccination. This does not mean that the vaccine caused the side effect. Reports may describe coincidental events, which have occurred post-vaccination, but would have occurred even if vaccination had not taken place (e.g. they may be due to an underlying medical condition, or be signs and symptoms of another illness). Only a detailed evaluation and scientific assessment of all available data allows for robust conclusions to be drawn on the benefits and risks of a vaccine.”

In the UK a report from the Office for National Statistics (ONS) shows the risk of dying from heart issues was three and a half times higher among young women in the first three months after a single dose of the AstraZeneca Covid vaccine.

ONS analysed hospitalisations, vaccination records and death registrations in England among 12 to 29 year-olds to assess the impact of the Covid-19 jab and infection.

After one dose of a non-mRNA vaccine, which includes the AstraZeneca jab, there was evidence of an increased risk of cardiac death in young women, the ONS said.

The link to the HPRA update